Fenofibrate Related Compound B
USP/1269618 - United States Pharmacopeia (USP) Reference Standard
Synonym: 2-
CAS Number: 42017-89-0
Empirical Formula (Hill Notation): C17H15ClO4
Molecular Weight: 318.75
MDL Number: MFCD00792461
Linear Formula: C17H15ClO4
Product Type: Chemical
| API family | fenofibrate |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C17H15ClO4/c1-17(2,16( |
| InChI key | MQOBSOSZFYZQOK-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | O=C(C1=CC=C(OC(C)(C)C(O)= |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Fenofibrate Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Fenofibrate • Fenofibrate Capsules • Fenofibrate Tablets |
| Disclaimer: | Sales restrictions may apply. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302 - H410 |
| Precautionary statements | P264 - P270 - P273 - P301 + P312 - P391 - P501 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| UNSPSC | 41116107 |



